metabolicMolecular Weight: 4113.6

Semaglutide

Ozempic • Wegovy

A widely used GLP-1 analog for type 2 diabetes and chronic weight management.

Shop Semaglutide

Mechanism

GLP-1 receptor agonist. Increases insulin secretion, decreases glucagon, and slows gastric emptying.

Half-Life

7 days

Administration

Subcutaneous

Technical Protocol

Semaglutide: Comprehensive Research Guide

Overview

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy). With a half-life of approximately 7 days, it allows for once-weekly administration.

Mechanism of Action

Binds to GLP-1 receptors
Stimulates insulin secretion
Suppresses glucagon
Slows gastric emptying
Reduces appetite

This information is for research and educational purposes only.

Peer-Reviewed Citations

Once-weekly semaglutide in adults with overweight or obesity

Wilding JPH, et al. • N Engl J Med (2021)

Access Research

Frequently Asked Questions

What is Semaglutide?

A widely used GLP-1 analog for type 2 diabetes and chronic weight management.

How does Semaglutide work?

GLP-1 receptor agonist. Increases insulin secretion, decreases glucagon, and slows gastric emptying.

What is the typical dosage of Semaglutide in research?

The typical research dosage of Semaglutide is 1 mg weekly (range: 0.25-2.4 mg weekly). Common administration routes include Subcutaneous.

How should Semaglutide be stored?

Store at 2-8°C, protect from light

Source Semaglutide for Your Research

Third-party tested, EU-shipped, certificate of analysis included. High-purity Semaglutide available from our verified research partner.